An Overview of Anticancer Herbal Medicines

作者: Addanki P. Kumar , Heather Graham , Craig Robson , Karthik Garapati , Rita Ghosh

DOI: 10.1007/978-94-007-0526-5_1

关键词:

摘要: The use of medicinal plants to help sustain good health and vitality reduce inflammation has an ancient respected history. Approximately 38% American adults are using some form complementary alternative medicine, resulting in $ 34 billion dollars spent annually. Herbal medicine compositions offer a potential advantage that they usually comprise multiple components interact act simultaneously through molecular targets signaling pathways. These complex often synergistic botanicals may also decrease toxicity increase bioavailability as strategies for cancer management. quality content the active supplement depends on collection, processing composition raw material extraction procedures. In addition, despite evidence usefulness mixtures cell culture pre-clinical animal models, there is no formal regulation natural supplements by United States Food Drug Administration, however, which creates conflict medical community, reluctance recommend herbals medicines patient care. Clinicians should be aware these alternatives given their future oncology role treatment when standard cures have been attempted clinical trials available patients with advanced disease. Further investigation focus herbs chemo-prevention chronic diseases certain cancers. advantages limitations various products into mainstream practice discussed.

参考文章(344)
Joanna Eng, Darlene Ramsum, Marja Verhoef, Emma Guns, Joyce Davison, Richard Gallagher, A Population-Based Survey of Complementary and Alternative Medicine Use in Men Recently Diagnosed with Prostate Cancer Integrative Cancer Therapies. ,vol. 2, pp. 212- 216 ,(2003) , 10.1177/1534735403256207
Barrie Cassileth, K. Simon Yeung, Jyothirmai Gubili, Herbs and Other Botanicals in Cancer Patient Care Current Treatment Options in Oncology. ,vol. 9, pp. 109- 116 ,(2008) , 10.1007/S11864-008-0061-5
Susan R Sturgeon, Alayne G Ronnenberg, Pomegranate and breast cancer: possible mechanisms of prevention. Nutrition Reviews. ,vol. 68, pp. 122- 128 ,(2010) , 10.1111/J.1753-4887.2009.00268.X
B. N. Ames, L. S. Gold, W. C. Willett, The causes and prevention of cancer Proceedings of the National Academy of Sciences of the United States of America. ,vol. 92, pp. 5258- 5265 ,(1995) , 10.1073/PNAS.92.12.5258
Ilaria De Stefano, Giuseppina Raspaglio, Gian Franco Zannoni, Daniele Travaglia, Maria Grazia Prisco, Marco Mosca, Cristiano Ferlini, Giovanni Scambia, Daniela Gallo, Antiproliferative And Antiangiogenic Effects Of The Benzophenanthridine Alkaloid Sanguinarine In Melanoma Biochemical Pharmacology. ,vol. 78, pp. 1374- 1381 ,(2009) , 10.1016/J.BCP.2009.07.011
Harish Kommera, Goran N. Kaluđerović, Martin Bette, Jutta Kalbitz, Petra Fuchs, Simone Fulda, Walter Mier, Reinhard Paschke, In vitro anticancer studies of α- and β-d-glucopyranose betulin anomers Chemico-Biological Interactions. ,vol. 185, pp. 128- 136 ,(2010) , 10.1016/J.CBI.2010.02.038
Hyunjin Park, Eric Bergeron, Helena Senta, Kim Guillemette, Sabrina Beauvais, Richard Blouin, Joël Sirois, Nathalie Faucheux, Sanguinarine induces apoptosis of human osteosarcoma cells through the extrinsic and intrinsic pathways Biochemical and Biophysical Research Communications. ,vol. 399, pp. 446- 451 ,(2010) , 10.1016/J.BBRC.2010.07.114
Hui-Jung Jung, Jong-Wook Park, Jason S. Lee, Seong-Ryong Lee, Byeong-Churl Jang, Seong-Il Suh, Min-Ho Suh, Won-Ki Baek, Silibinin inhibits expression of HIF-1α through suppression of protein translation in prostate cancer cells Biochemical and Biophysical Research Communications. ,vol. 390, pp. 71- 76 ,(2009) , 10.1016/J.BBRC.2009.09.068
Syed M Meeran, Shweta N Patel, Trygve O Tollefsbol, None, Sulforaphane Causes Epigenetic Repression of hTERT Expression in Human Breast Cancer Cell Lines PLoS ONE. ,vol. 5, pp. e11457- ,(2010) , 10.1371/JOURNAL.PONE.0011457